| Identification | Back Directory | [Name]
2,4-Pyrimidinediamine, N4-(8-methyl-4-cinnolinyl)-N2-[4-(4-morpholinyl)phenyl]- | [CAS]
2785430-89-7 | [Synonyms]
ALK5-IN-33 2,4-Pyrimidinediamine, N4-(8-methyl-4-cinnolinyl)-N2-[4-(4-morpholinyl)phenyl]- | [Molecular Formula]
C23H23N7O | [MOL File]
2785430-89-7.mol | [Molecular Weight]
413.48 |
| Hazard Information | Back Directory | [Uses]
ALK5-IN-33 (Compound EX-10) is a selective, orally active ALK-5 inhibitor with an IC50 ≤10 nM[1]. | [in vivo]
ALK-IN-33 (Compound EX-10) (10-100 mg/kg; i.g.; once) reduces the phospho SMAD2 levels in a dose dependent fashion in A549 xenograft model in mice[1]. | Animal Model: | Female athymic nude mice, A549 xenograft model[1] | | Dosage: | 10, 50, 75 and 100 mg/kg | | Administration: | Oral gavage, once
| | Result: | Reduced the phospho SMAD2 levels (p-SMAD2) in a dose dependent fashion. |
| [IC 50]
ALK5: ≤10 nM (IC50); ALK2 | [References]
[1] Bettina FRANZ, et al. Alk-5 inhibitors and uses thereof. Patent WO2022126133A1. |
|
|